PDF(859 KB)
Research progress in promoting synaptic regeneration in neurodegenerative diseasesy
Shengchun LOU, Chengye ZHAO, Suqin ZHOU, Shixin LI
Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2026, Vol. 9 ›› Issue (5) : 349-356.
PDF(859 KB)
Abbreviation (ISO4): Chinese Journal of Alzheimer's Disease and Related Disorders
Editor in chief: Jun WANG
PDF(859 KB)
Research progress in promoting synaptic regeneration in neurodegenerative diseasesy
Synaptic dysfunction and loss are early core pathological events in neurodegenerative diseases. This article systematically reviews the cellular and molecular mechanisms underlying synaptic dysfunction, identifying the dysregulation of neurons, astrocytes, and microglia as the core cellular mechanism. Furthermore, it highlights the intertwined pathological networks of neuroinflammation, metabolic disorder, and protein homeostasis imbalance, which collectively drive the vicious cycle of synaptic dysfunction. Additionally, the article introduces the synaptic regeneration regulatory system centered around brain-derived neurotrophic factor and summarizes emerging therapeutic strategies such as small molecule drugs targeting multiple pathways, cell and gene therapies, non-coding RNA regulation, and non-pharmacological interventions. Furthermore, it discusses the application of cutting-edge technologies such as synaptic density PET imaging, induced pluripotent stem cells (iPSC), and brain organoids in synaptic regeneration research. In the future, the treatment of neurodegenerative diseases may shift from single-target approaches to multidimensional interventions, integrating various therapies and lifestyle adjustments to achieve a leap from delaying disease progression to functional restoration.
Neurodegenerative diseases / Synapse regeneration / Pathological mechanisms / Therapeutic strategies
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
利益冲突声明 所有作者均不存在利益冲突。
/
| 〈 |
|
〉 |